Ontology highlight
ABSTRACT: Introduction
Inflammatory bowel diseases (IBDs) are chronic diseases of unknown cause characterised by a progressive and unpredictable disease course. In the last decade, biological treatment has become a cornerstone in the treatment of IBD. However, one-in-three-to-four patients do not respond to first-line biological agents and another third of patients see their response diminish over time. This highlights an unmet need for optimising the use of biologicals and the prediction of treatment response. Considering the multifaceted nature of IBD, we hypothesise that multiomics profiling of sequential samples from single patients could facilitate the discovery of predictive biomarkers of response to biological therapy and disease course.Methods
This is a multicentre prospectiv
SUBMITTER: Zhao M
PROVIDER: S-EPMC7045223 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature